Fenfluramine: New Treatment for Seizures in Dravet Syndrome

Pediatr Neurol Briefs. 2020 Mar 12;34:8. doi: 10.15844/pedneurbriefs-34-8.


Investigators for the FAiRE DS Study Group assessed the efficacy and safety of Fenfluramine for treating seizures in patients less than 18 y.o. with Dravet Syndrome in an international double-blind, placebo-controlled clinical trial. A total of 119 patients (mean age 9.0 y, 54% male) were enrolled in the study.

Keywords: Dravet Syndrome; Fenfluramine; Seizures.

Publication types

  • Comment